ask="N/A"
ask_size="N/A"
average_daily_volume="435475"
bid="16.14"
bid_size="5000"
book_value="8.12"
change="-0.28"
change_from_200_day_moving_average="-1.39"
change_from_50_day_moving_average="-1.25"
change_from_52_week_high="-5.60"
change_From_52_week_low="7.37"
change_in_percent="-1.45%"
close="18.97"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.29"
ebitda="-18.48M"
eps_estimate_current_year="-0.96"
eps_estimate_next_quarter="-0.20"
eps_estimate_next_year="-1.21"
ex_dividend_date="N/A"
float_shares="23627000"
high="19.49"
high_52_weeks="24.57"
last_trade_date="3/16/2017"
last_trade_price="18.97"
last_trade_size="21608"
last_trade_time="4:00pm"
low="18.79"
low_52_weeks="11.60"
market_capitalization="722.62M"
moving_average_200_day="20.36"
moving_average_50_day="20.22"
name="Retrophin
Inc."
notes="N/A"
one_year_target_price="33.33"
open="19.23"
pe_ratio="N/A"
peg_ratio="-1.00"
percent_change_from_200_day_moving_average="-6.81%"
percent_change_from_50_day_moving_average="-6.20%"
percent_change_from_52_week_high="-22.79%"
percent_change_from_52_week_low="+63.53%"
previous_close="19.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.37"
price_per_sales="5.49"
revenue="133.59M"
shares_outstanding="38093000"
short_ratio="15.52"
stock_exchange="NGM"
symbol="RTRX"
volume="249192"
weeks_range_52="11.60 - 24.57"
